We will be undertaking the cost-effectiveness analysis for the randomised controlled trial of e-cigarettes over and above standard pharmacotherapy when used within the UK Stop Smoking Service. The trial aims to determine the 12-month sustained biochemically validated abstinence rates in smokers using EC compared to smokers using standard NRT. Abstinence rates are measured at 4 weeks and 6 months, together with the effects of the two treatments on smoking reduction in participants who did not achieve full abstinence and ratings of the two treatment approaches by patients.
Funder(s): | NCCHTA |
Start Date: | 1-Oct-2014 |
Expiry Date: | 31-Mar-2018 |